Sean Salmon compensation by year
Medtronic Summary Compensation Table · all 3 fiscal years held| Component | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Salary | $867,000 | $867,000 | $884,654 |
| Bonus | $0 | $0 | $0 |
| Stock awards | $2,905,963 | $3,406,800 | $4,537,157 |
| Option awards | $1,200,013 | $1,274,992 | $1,725,131 |
| Non-equity incentive | $0 | $774,952 | $823,050 |
| Pension and deferred compensation | $357,701 | $185,359 | $382,886 |
| All other | $33,968 | $39,684 | $43,719 |
| Total | $5,364,646 | $6,548,787 | $8,396,597 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Medtronic plc DEF 14A filed January 1, 1900, accession 0001613103-25-000151, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Medtronic plc filed document, accession 0001613103-25-000151. Every figure is read from that document and cited to the page and table it appears in. Filed January 1, 1900.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 36,843 | $3,100,707 | — |
| PSU | 25,706 | $2,163,417 | — |
| PSU | 23,575 | $1,984,072 | — |
| RSU | 14,081 | $1,185,057 | — |
| RSU | 9,826 | $826,956 | — |
| RSU | 9,104 | $766,193 | — |
| Option | 51,147 | — | $87.76 |
| Option | 33,962 | — | $93.08 |
| Option | 106,260 | — | $80.00 |
| Option | 272 | — | $131.26 |
| Option | 11,717 | — | $131.26 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Medtronic plc's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Medtronic’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Geoff Martha | Chairman and Chief Executive Officer | $21,240,058 |
| Sean Salmon · this page | Former EVP & President, Cardiovascular Portfolio | $8,396,597 |
| Brett Wall | Former Executive Vice President and President, Neuroscience Portfolio | $8,121,213 |
| Gregory Smith | EVP Enterprise Operations | $8,083,981 |
| Thierry Piéton | Executive Vice President and Chief Financial Officer | $5,212,448 |
| Gary Corona | Former SVP Corporate Finance (former Interim CFO) | $3,795,248 |
| Karen Parkhill | Former Executive Vice President and Chief Financial Officer | $270,679 |
The full Medtronic compensation record
free company briefThis page is one person within Medtronic's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Medtronic proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Medtronic's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.